Роль послеоперационной лучевой терапии в лечении больных раком молочной железы
Реферат
Обзор посвящен вопросам применения лучевой терапии у больных раком молочной железы после выполнения радикальной мастэктомии. Представлена проблема выбора объема адъювантной лучевой терапии с учетом клинико-морфологических факторов прогноза.
Тэги
Список литературы1. Бекуазарова Н.В. Современные подходы к диагностике и лечению рака молочной железы IIб стадии: автореф. дис. … канд. мед. наук. М., 2009.
2. Вторушин С.В., Перельмутер В.М., Завьялова М.В. и др. Синхронное и метахронное развитие локальных рецидивов и отдаленных метастазов у больных раком молочной железы // Сиб. онкол. журн. 2011. (2). 27–31.
3. Вторушин С.В. Клинико-морфологические особенности мультицентрического роста и рецидивирования при раке молочной железы: автореф. дис. … докт. мед. наук. Томск, 2011.
4. Геворкян В.С. Современные возможности внутритканевой лучевой терапии в комбинированном и комплексном лечении рака молочной железы центральной и медиальной локализации: автореф. дис. … канд. мед. наук. М., 2008.
5. Жогина Ж.А., Слонимская Е.М., Мусабаева Л.И. Влияние клинико-морфологических факторов на течение и прогноз ранних форм рака молочной железы // Сиб. онкол. журн. 2003. 3. (7). 7–10.
6. Курносов А.А. Ускоренные режимы лучевой терапии больных раком молочной железы IIb-III стадии: автореф. дис. … канд. мед. наук. М., 2008.
7. Понкратова Ю.А., Хмелевский Е.В., Добровольская Н.Ю. Целесообразность снижения дозы постмастэктомической лучевой терапии при комплексном лечении местно-распространенного рака молочной железы // Вестн. Рос. науч. центра рентгенорадиологии. 2011. 11. http://vestnik.rncrr.ru/vestnik/v11/papers/poncrat_v11.htm.
8. Семиглазов В.Ф., Семиглазов В.В., Дашян Г. А. Обоснование международных стандартов лечения операбельных форм рака молочной железы. Пособие для врачей. СПб., 2009. 57 с.
9. Щепотин И.Б., Зотов А.С., Зайчук В.В. Факторы риска развития местных рецидивов инвазивного рака молочной железы // Онкология. 2010. 4. (12). 347–350.
10. Abi-Raad R., Boutrus R., Wang R. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy // Int. J. Radiat. Oncol. Biol. 2011. 81. 151–157.
11. Anderson P., Freedman G., Li T. et al. Post-mastectomy radiation for node-negative breast cancer: Is regional node coverage always needed? // Int. J. Radiat. Oncol. Biol. Phys. 2008. 72. S194.
12. Buchholz T.A., Katz A., Strom E.A. et al. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2002. 53. (4). 880–888.
13. Carlson R.W., Allred D.C., Anderson B.O. et al. Breast cancer clinical practice guidelines in oncology // J. Natl. Compr. Canc. Netw. 2009. 7. 122–192.
14. Ceilley E., Jagsi R., Goldberg S. et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey // Int. J. Radiat. Oncol. Biol. Phys. 2005. 61. (2). 365–367.
15. Cheng S.H., Horng C.-H., West M. et al. Genomic prediction of locoregional recurrence after mastectomy in breast cancer // J. Clin. Oncol. 2006. 24. 4594–4602.
16. Early Breast Cancer Trialists’ Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials // Lancet. 2000. 355. 1757–1770.
17. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials // Lancet. 2005. 366. 2087–2106.
18. Fletcher G.H., McNeese M.D., Oswald M.J. Long-range results for breast cancer patients treated by radical mastectomy and postoperative radiation without adjuvant chemotherapy: an update // Int. J. Radiat. Oncol. Biol. Phys. 1989. 17. (1). 11–14.
19. Garg A.K., Strom E.A., McNeese M.D. et al. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2004. 59. (1). 138–145.
20. Gebski V., Lagleva M., Keech A. et al. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: A clinical perspective // J. Natl. Cancer Inst. 2006. 98. 26–38.
21. Goldhirsch A., Ingle J.N., Gelber R.D. et al. Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer // Ann. Oncol. 2009. 20. 1319–1329.
22. Gruber G., Cole B.F., Castiglione-Gertsch M. et al. Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer // Ann. Oncol. 2008. 19. 1393–1401.
23. Hamamoto Y., Shinohara S., Nakajima N. et al. Impact of aggregate of risk factors for isolated locoregional failure in breast cancer patients treated with mastectomy without radiotherapy // Breast Cancer. 2012. DOI 10.1007/s12282-012-0335-4.
24. Jagsi R., Raad R.A., Goldberg S. et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation // Int. J. Radiat. Oncol. Biol. Phys. 2005. 62. 1035–1039.
25. Katz A., Strom E.A., Buchholz T.A. et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation // J. Clin. Oncol. 2000. 18. 2817–2827.
26. Kunkler I., Russell N., Canney P. et al. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective // J. Natl. Cancer Inst. 2006. 98. 1020–1021.
27. Lee J.C., Truong P.T., Kader H.A. et al. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer // Clin. Oncol. 2005. 17. (8). 623–629.
28. Livi L., Meattini I., Di Cataldo V. et al. Postmastectomy radiotherapy in breast cancer adjuvant treatment // Minerva Chir. 2010. 65. (5). 527–536.
29. Nagao T., Kinoshita T., Tamura N. et al. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy // Int. J. Clin. Oncol. 2011. DOI.10.1007/s10147-011-0343-y.
30. Nielsen H.M., Overgaard M., Grau C. et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies // J. Clin. Oncol. 2006. 24. (15). 2268–2275.
31. Nixon A., Neuberg D., Hayes D. et al. Relationship of patients age to pathologic features of the tumor and prognosis for patients with stage 1 or 11 breast cancer // J. Clin. Oncol. 1994. 12. 888–894.
32. Olivotto I.A., Truong P.T., Chua B. Postmastectomy radiation therapy: who needs it? // J. Clin. Oncol. 2004. 22. (21). 4237–4239.
33. Overgaard M., Hansen P.S., Overgaard J. et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy // N. Engl. J. Med. 1997. 337. 949–955.
34. Overgaard M., Jensen J., Overgaard J. et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial // Lancet. 1999. 353. 1641–1648.
35. Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials // Radiother. Oncol. 2007. 82. (3). 247−253.
36. Panoff J.E., Takita C., Hurley J. et al. Higher chest wall dose results in improved locoregional outcome in patients receiving postmastectomy radiation // Int. J. Radiat. Oncol. Biol. Phys. 2012. 82. (3).1192–1199.
37. Poortmans P. Evidence based radiation oncology: Breast cancer // Radiother. Oncol. 2007. 84. 84–101.
38. Recht A., Gray R., Davidson N.E. et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group // J. Clin. Oncol. 1999. 17. 1689–700.
39. Recht A., Edge S., Solin L. et al. Postmastectomy radiotherapy guidelines of the American Society of Clinical Oncology // J. Clin. Oncol. 2001. 19. 1539–1569.
40. Russell N., Kunkler I., Canney P. et al. Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate? // J. Clin. Oncol. 2009. 27. 996–1001.
41. Schiffman S.C., McMasters K.M., Scoggins C.R. et al. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients. // J. Am. Coll. Surg. 2011. 213. 45–52.
42. Sharma R., Bedrosian I., Lucci A. et al. Present-day locoregional control in patients with T1 or T2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy // Ann. Surg. Oncol. 2010. 17. 2899–2908.
43. Strom E.A., Woodward W.A., Katz A. et al. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2005. 63. 1508–1513.
44. Taylor M.E., Haffty B.G., Rabinovitch R. et al. ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast // Int. J. Radiat. Oncol. Biol. Phys. 2009. 73. (4). 997–1002.
45. Truong P.T., Woodward W.A., Thames H.D. et al. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1–3 positive nodes: an analysis of prospective data from British Columbia and the M.D. Anderson Cancer Center // Int. J. Radiat. Oncol. Biol. Phys. 2007. 68. 59–65.
46. Veronesi U., Arnone P., Veronesi P. et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. results on a large series // Ann. Oncol. 2008. 19. 1553–1560.
47. Vinh-Hung V., Verkooijen H.M., Fioretta G. et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer // J. Clin. Oncol. 2009. 27. 1062–1068.
48. Woodward W.A., Strom E.A., Tucker S.L. et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation // Int. J. Radiat. Oncol. Biol. Phys. 2003. 57. 336–344.
49. Yarnold J., Ashton A., Bliss J. et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomized trial // Radiother. Oncol. 2005. 75. 9–17.
50. Yildirum E. Locoregional recurrence in breast carcinoma patients // Eur. J. Surg. Oncol. 2009. 35. 258–265.
Симонов К.А. – аспирант отделения радиологии, e-mail: simonov_ ka@bk.ru
Старцева Ж.А. – д.м.н., рук. отделения радиологии, e-mail: zhanna.alex@rambler.ru
Слонимская Е.М. – д.м.н., проф., рук. отделения общей онкологии
